Bionano Announces Publication that Demonstrates OGM’s Utility for Resolving Complex…
<!-- Name:DistributionId Value:8803417 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Bionano Genomics
Bionano Shares Overview of AGBT Pre-Conference Workshop Program Along with Details of…
<!-- Name:DistributionId Value:8749415 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Bionano Strategy Day Highlighted the Company’s Strategic Initiatives and Growth Plans…
<!-- Name:DistributionId Value:8746569 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Bionano Genomics Announces the Final Speaker Lineup for Symposium 2023 with 30 OGM…
27 different customers representing North America and Europe30 oral presentations across four consecutive days34 scientific posters will be featured in a virtual exhibition hallTopics span…
Multi-Center Research Study Illustrates How OGM Can Potentially Result in More…
Researchers from eight research institutes recommend OGM as first-line analysis for AML due to its ability to perform better and cost less than analysis with karyotyping, FISH, and CMAOGM…
Bionano Genomics Announces American Society of Hematology (ASH) Annual Meeting…
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for…
OGM Evaluated as a Method for Investigating Abnormal NIPT Results due to its Ability…
SAN DIEGO, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a peer-reviewed study evaluating optical genome mapping (OGM) as a…
Bionano Genomics Announces Publication of Study Using OGM for Detection of Balanced…
SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study utilizing OGM to detect cryptic balanced chromosomal…
Bionano Genomics Announces the First Publication Using OGM to Analyze Impact of…
SAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to use optical genome mapping (OGM) to analyze the…
Bionano Genomics Announces Peer-Reviewed Publication of NeuroSCORE Model to Predict…
SAN DIEGO, April 29, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™…